Kaposi's sarcoma-associated herpes virus and acquired immunodeficiency syndrome-related malignancy

Seminars in Oncology

Volumn 27, Issue 4 SUPPL., 2000, Pages 409-419

  Cannon, M ^a   Cesarman, E ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; VIRUS DNA; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; REVIEW; VIRUS GENOME; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; LYMPHOMA, AIDS-RELATED; SARCOMA, KAPOSI;

EID: 0033894113     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
2. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma
3. Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease
4. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa
5. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells
6. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas
7. Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus
8. Multicentric Castleman's disease
9. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission
10. Kaposi's sarcoma in childhood: An analysis of 100 cases from Uganda and relationship to HIV infection
11. Occurrence of Kaposi's sarcoma in renal transplant recipients treated with low doses of cyclosporine
12. Epidemiology of classic Kaposi's sarcoma, with special reference to Mediterranean population
13. Disseminated Kaposi's sarcoma syndrome in young homosexual men
14. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma
15. Kaposi's sarcoma: A review of gene expression and ultrastructure of KS spindle cells in vivo
16. Heterogeneity of spindle cells in Kaposi's sarcoma: Comparison of cells in lesions and in culture
17. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro
18. Monoclonal origin of multicentric Kaposi's sarcoma lesions
19. Evidence for multiclonality in multicentric Kaposi's sarcoma
20. Isolation of spindle-shaped cell populations from primary cultures of Kaposi's sarcoma of different stage
21. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome
22. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus
23. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences
24. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen
25. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma
26. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985
27. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients
28. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma
29. Sexual transmission and the natural history of human herpesvirus 8 infection
30. HHV8 DNA in normal gastrointestinal mucosa from HIV seropositive people
31. Detection of Kaposi's sarcoma herpesvirus DNA in semen of homosexual men with Kaposi's sarcoma
32. Kaposi's sarcoma-associated herpesvirus-like DNA sequences (KSHV/HHV-8) in oral AIDS-Kaposi's sarcoma: A PCR and clinicopathologic study
33. Kaposi's sarcoma-associated herpesvirus: Epidemiology, virology, and molecular biology
34. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients
35. Risk of other cancers following Kaposi's sarcoma: Relation to acquired immunodeficiency syndrome
36. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986)
37. Primary lymphomatous effusions in AIDS: A morphological, immunophenotypic, and molecular study
38. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas
39. The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases
40. Kaposi's sarcoma-associated herpesvirus: A lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease
41. Primary effusion lymphoma containing human herpesvirus 8 DNA in two AIDS patients with Kaposi's sarcoma
42. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
43. Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions
44. Effect of DNA synthesis inhibitors on Kaposi's sarcoma-associated herpesvirus cyclin and major capsid protein gene expression
45. Multicentric Castleman's disease in HIV infection: A clinical and pathological study of 20 patients
46. Atypical lymphoproliferative disorders
47. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease
48. Lymphotropic herpesvirus (EPV, HHV-6, HHV-8) DNA sequences in HIV-negative Castleman's disease
49. Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells
50. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions
51. KSHV strains: The origins and global spread of the virus
52. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma
53. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells
54. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1)
55. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression
56. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma
57. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins
58. A novel cyclin encoded by a bcl1-linked candidate oncogene
59. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak
60. Immunihistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma
61. Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue
62. Treatment of HIV-associated Kaposi's sarcoma with paclitaxel
63. ICE family proteases in inflammation and apoptosis
64. Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter
65. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway
66. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor confers resistance to the antiproliferative effect of interferon-alpha
67. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor
68. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2)
69. Interleukin 6 IL-6, and its receptor: Their role in plasma cell neoplasias
70. Interleukin-6 gene expression in Castleman's disease
71. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease
72. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease
73. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation
74. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator
75. Expanding horizons for receptors coupled to G proteins: Diversity and disease
76. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines
77. Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor
78. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus
79. Identification of kaposin open reading frame (K12) as a human herpesvirus 8 Kaposi's sarcoma-associated herpesvirus, transforming gene
80. gamma-Interferon production in peripheral blood mononuclear cells and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: Correlation with the presence of human herpesvirus-8 in peripheral blood mononuclear cells and lesional macrophages
81. Pathogenesis and cell biology of Kaposi's sarcoma
82. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects
83. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development
84. Block of AIDS-Kaposi's sarcoma KS, cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS
85. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma
86. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8
87. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma
88. Some aspects of the pathogenesis of HIV-1-associated Kaposi's sarcoma
89. Identification of human herpesvirus 8-specific cytotoxic T-cell responses
90. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: Association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels
91. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma